Abstract: A request is received from a first user of a social interaction platform. The request is a request to acquire a status. In response to the receiving of the request, a database is accessed. The database contains first electronic data pertaining to previous interactions between the first user and other entities of the social interaction platform. The first electronic data is analyzed via one or more Natural Language Processing (NLP) techniques. A first result is obtained based on the analyzing. A machine learning process is executed based at least in part on the first result. Based on the executing of the machine learning process, a determination is made whether to grant or deny the request received from the first user.

Abstract: A method of prognosing a subject diagnosed with multiple myeloma (MM) is provided. Also provided a method of treating a subject diagnosed with MM selected expressing intracellular PPIA and/or RRM2 above a predetermined threshold, the method comprising administering to the subject a therapeutically effective amount of at least one agent which specifically down-regulates activity or expression of PPIA and/or RRM2, thereby treating the subject.

Abstract: The present disclosure provides a method of automatically extracting data from web pages and analyzing the extracted data to generate an output. A plurality of web pages of a plurality of merchants is accessed. Based on the accessing of the web pages, a subset of the plurality of web pages is identified as inventory pages that contain information about products or services offered for sale. The inventory pages are electronically scanned to extract a price for each of the products or services. An output is generated that includes a listing of the products or services and prices associated with the products or services, respectively.

Abstract: A request is received from a first user of a social interaction platform. The request is a request to acquire a status. In response to the receiving of the request, a database is accessed. The database contains first electronic data pertaining to previous interactions between the first user and other entities of the social interaction platform. The first electronic data is analyzed via one or more Natural Language Processing (NLP) techniques. A first result is obtained based on the analyzing. A machine learning process is executed based at least in part on the first result. Based on the executing of the machine learning process, a determination is made whether to grant or deny the request received from the first user.

Abstract: The present disclosure provides a method of automatically extracting data from web pages and analyzing the extracted data to generate an output. A plurality of web pages of a plurality of merchants is accessed. Based on the accessing of the web pages, a subset of the plurality of web pages is identified as inventory pages that contain information about products or services offered for sale. The inventory pages are electronically scanned to extract a price for each of the products or services. An output is generated that includes a listing of the products or services and prices associated with the products or services, respectively.

Abstract: The present disclosure provides a method of automatically extracting data from web pages and analyzing the extracted data to generate an output. A plurality of web pages of a plurality of merchants is accessed. Based on the accessing of the web pages, a subset of the plurality of web pages is identified as inventory pages that contain information about products or services offered for sale. The inventory pages are electronically scanned to extract a price for each of the products or services. An output is generated that includes a listing of the products or services and prices associated with the products or services, respectively.

Abstract: The present invention relates to modified polysaccharide-based self-assembled aggregates capable to encapsulate and deliver active agents into and between media of different hydrophilicity/hydrophobicity.

Abstract: A system and method for assessing the risk of a listing that transforms information from the listing into variables suitable for a classifier trained to score the riskiness of listings and using the score in addition to predetermined variable constraints to determine whether a listing is fraudulent.

Abstract: Methods of treating a malignant glioma in a subject are disclosed. The methods comprise administering to the subject a therapeutically effective amount of a viral vector comprising: (i) a first polynucleotide sequence encoding a Fas-chimera (Fas-c), said first polynucleotide sequence comprising SEQ ID NOs: 2 and 3; and (ii) a second polynucleotide sequence encoding an endothelial cell-specific promoter or a periendothelial cell-specific promoter.

Abstract: A system and method for assessing the risk of a listing that transforms information from the listing into variables suitable for a classifier trained to score the riskiness of listings and using the score in addition to predetermined variable constraints to determine whether a listing is fraudulent.

Abstract: A system, method, and computer program product are provided for performing operations on network files including captured billing event information. In use, at least one network file is generated in response to a data capture command associated with a communications network, the at least one network file including information associated with a plurality of billing events corresponding to the communication network. Additionally, user input is received to perform at least one operation corresponding to the at least one network file, the at least one operation including at least one of: editing the at least one network file; filtering the at least one network file, based on configurable criteria; replaying at least a portion of the plurality of billing events included in the at least one network file; and generating an event template utilizing at least a portion of the information associated with the plurality of billing events.

Abstract: Anti-angiogenic adenovirus vectors, and therapeutic use thereof are provided, and more particularly, but not exclusively, clinical protocols for treatment of solid tumors in patients with an Ad5-PPE-1-3X-fas-chimera adenovirus vector.

Abstract: Methods of treatment which utilize co-administration of the oxidized lipid VB-201 with an additional therapeutically active agent are described herein. Methods of treating a cardiovascular disease are described herein, comprising co-administration of VB-201 and a statin to a subject who is not fully responsive to the statin, as well as methods of treating an inflammatory disease or disorder, comprising co-administration of VB-201 and glatiramer acetate. A pharmaceutical composition comprising VB-201, identified for use in combination with glatiramer acetate, is also described herein. Methods of determining a therapeutically effective amount of VB-201 in a subject and of determining a therapeutically effective amount of VB-201 for co-administration with an additional therapeutically active agent are also described. Novel until dosage forms of VB-201 and methods utilizing same are also disclosed.

Abstract: Provided is a simulant material including a primary explosive and a carrier.

Abstract: The present invention provides a simulant material comprising a primary explosive and a carrier.

Abstract: Anti-angiogenic adenovirus vectors, and therapeutic use thereof are provided, and more particularly, but not exclusively, clinical protocols for treatment of solid tumors in patients with an Ad5-PPE-1-3X-fas-chimera adenovirus vector.

Abstract: Methods of treating a malignant glioma in a subject are disclosed. The methods comprise administering to the subject a therapeutically effective amount of a viral vector comprising: (i) a first polynucleotide sequence encoding a Fas-chimera (Fas-c), said first polynucleotide sequence comprising SEQ ID NOs: 2 and 3; and (ii) a second polynucleotide sequence encoding an endothelial cell-specific promoter or a periendothelial cell-specific promoter.

Abstract: Anti-angiogenic adenovirus vectors, and therapeutic use thereof are provided, and more particularly, but not exclusively, clinical protocols for treatment of solid tumors in patients with an Ad5-PPE-1-3X-fas-chimera adenovirus vector.

Abstract: Anti-angiogenic adenovirus vectors, and therapeutic use thereof are provided, and more particularly, but not exclusively, clinical protocols for treatment of solid tumors in patients with an Ad5-PPE-1-3X-fas-chimera adenovirus vector.

Abstract: Methods of treating a malignant glioma in a subject are disclosed. The methods comprise administering to the subject a therapeutically effective amount of a viral vector comprising: (i) a first polynucleotide sequence encoding a Fas-chimera (Fas-c), said first polynucleotide sequence comprising SEQ ID NOs: 2 and 3; and (ii) a second polynucleotide sequence encoding an endothelial cell-specific promoter or a periendothelial cell-specific promoter.